✦ LIBER ✦

Multiple sclerosis, sleep latencies and HLA antigens

✍ Scribed by L. Rumbach; M. M. Tongio; J. M. Warter; M. Collard; D. Kurtz

Publisher: Springer
Year: 1989
Tongue: English
Weight: 212 KB
Volume: 236
Category: Article
ISSN: 0340-5354
DOI: 10.1007/bf00314465

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

HLA-antigens and the prognosis of multip

HLA-antigens and the prognosis of multiple sclerosis

✍ Sigrid Poser; G. Ritter; H. J. Bauer; H. Grosse-Wilde; E. K. Kuwert; N. E. Raun 📂 Article 📅 1981 🏛 Springer 🌐 English ⚖ 143 KB

The histocompatibility pattern of 160 patients with multiple sclerosis (MS) living in the epidemiological area of Southern Lower Saxony was determined and compared to a control population. The only significant difference was the more frequent occurrence of DW2 in the patient group (44% vs. 21%). Tak

HLA antigens in Italian multiple scleros

HLA antigens in Italian multiple sclerosis patients

✍ L. La Mantia; M. T. Illeni; C. Milanese; A. Salmaggi; M. Eoli; G. Pellegris; A. 📂 Article 📅 1991 🏛 Springer Milan 🌐 English ⚖ 432 KB

HLA antigens and progression of multiple

HLA antigens and progression of multiple sclerosis. Part II

✍ L. Dejaegher; M. Bruyere; P. Ketelaer; H. Carton 📂 Article 📅 1983 🏛 Springer 🌐 English ⚖ 375 KB

The HLA-A, -B, -C and -D were determined in 200 multiple sclerosis (MS) patients, 64 of whom underwent a CSF examination. Their frequencies were correlated with the rate of disease progression and with factors thought to influence disease progression, including onset age, type of clinical course and

HLA and prognosis in multiple sclerosis

✍ Björn Runmarker; Tommy Martinsson; Jan Wahlström; Oluf Andersen 📂 Article 📅 1994 🏛 Springer 🌐 English ⚖ 581 KB

HLA antigens-linked genetic control in m

HLA antigens-linked genetic control in multiple sclerosis patients resistant and susceptible to infection

✍ G. Lamoureux; P. Duquette; Y. Lapierre; B. Cosgrove; G. Bourret; L. Labrie 📂 Article 📅 1983 🏛 Springer 🌐 English ⚖ 739 KB

Patients with multiple sclerosis (MS) from the two Montreal MS clinics, were divided into two groups: one group of 61 patients (MS type I) who had no clinical history of susceptibility to recurrent respiratory tract infections and a second group of 58 patients (MS type II) who had persistent suscept

HLA-DRB1 and disease outcome in multiple

HLA-DRB1 and disease outcome in multiple sclerosis

✍ S. J. M. Weatherby; W. Thomson; L. Pepper; R. Donn; J. Worthington; C. L. A. Man 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 225 KB